Mortality and 30-day readmission rate following leadless pacemaker implantation: insights from the Nationwide Readmissions Database

Back

ESC Professional Premium Access

Mortality and 30-day readmission rate following leadless pacemaker implantation: insights from the Nationwide Readmissions Database

Session: Pacing innovations

Topic: Device Treatment

Speaker: Doctor R. Tonegawa-Kuji (Suita, JP)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Reina Tonegawa-Kuji

National Cerebral & Cardiovascular Center, Suita (Japan)

0 follower

5 more presentations in this session

Clinical impact of "minimal" right ventricular pacing on atrial arrhythmias: results from the prospective multi-center worldwide EMERALD study.

Speaker: Doctor A. Di Cori (Pisa, IT)

Chronic outcomes of leadless vs transvenous single chamber ventricular pacemakers in high-risk subgroups

Speaker: Mr L. Higuera (Mounds View, US)

Evaluation of the association between right ventricular lead placement and future need for upgrade from pacemaker or ICD to cardiac resynchronization therapy. A population-based comparative study

Speaker: Associate Professor R. Borgquist (Copenhagen, DK)

Acute hemodynamic effects of biventricular pacing studied during cardiovascular magnetic resonance imaging: The PICARIA Trial

Speaker: Mr L. Hopman (Amsterdam, NL)

Intracardiac echocardiographically guided permanent pacemaker implantation is a feasible imaging tool with comparable procedural efficacy and safety

Speaker: Professor S. Shin (Seoul, KR)

Access the full session

Pacing innovations

Speakers: Doctor R. Tonegawa-Kuji, Doctor A. Di Cori, Mr L. Higuera, Associate Professor R. Borgquist, Mr L. Hopman...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources